Triazene metabolism IV. Derivatives of hydroxymethyltriazenes: Potential prodrugs for the active metabolites of the anti-tumour triazene, DTIC

Anti-Cancer Drug Design

Volumn 1, Issue 1, 1985, Pages 27-36

  Cameron, L M ^a   LaFrance, R J ^a   Hemens, C M ^a   Vaughan, K ^b   Rajaraman, R ^b   Chubb, D C ^b   Goddard, P M ^b  

^a SAINT MARY S UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 (3 ACETOXYMETHYL 3 METHYL 1 TRIAZENO)IMIDAZOLE 4 CARBOXAMIDE; ACETOXYMETHYLTRIAZENE DERIVATIVE; DACARBAZINE; HYDROXYMETHYLTRIAZENE DERIVATIVE; METHYLTRIAZENE DERIVATIVE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CELL STRAIN LI; CELL STRAIN NP; CELL STRAIN PC6A; DRUG COMPARISON; DRUG CYTOTOXICITY; DRUG METABOLISM; DRUG SCREENING; DRUG STABILITY; DRUG SYNTHESIS; IN VITRO STUDY; INTOXICATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA P 388; LYMPHOMA; LYMPHOMA TLX 5; MOUSE; NONHUMAN; PLASMACYTOMA; THERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; DACARBAZINE; DRUG STABILITY; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; PRODRUGS; TRIAZENES; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0022318878     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)